Arzneimittel Wirkungen, E. Mutschler (1981). |
Angewandte Chemie, 24(3) :186-197 (1985). |
S. Torii et al., J. Org. Chem. 56:3633 (1991). |
H. Kamachi et al., J. Antibiotics 41(11) :1602 (1988). |
K. Fujimoto et al., J. Antibiotics 40(3) :370 (1987). |
T. Nishimura et al., J. Antibiotics 40(1) :81 (1987). |
E. Defossa et al., Abstract No. 187, Cefdaloxime Pentexil Tosilate (HR916K) : a Diastereomerically Pure Novel Oral Cephalosporinester: Synthesis and Antibacterial Activity In Vivo (Oct. 11-14, 1991). |
D. Isert et al., Abstract No. 188, Cefdaloxime Pentexil Tosilate (HR916K) : a Diastereomerically Pure Novel Oral Cephalosporinester with Outstanding Absorption Characteristics (Oct. 11-14, 1991). |
"Cefpodoxime Proxetil", Drugs of the Future, 14(1):73-74 (1989). |
"SCE-2174", Drugs of the Future, 13(3):231-233 (1988). |
"Cefuroxime Axetil", Drugs of the Future, 10(2):112-113 (1985). |
"Beta-Lactam Compounds", Chemical Abstracts, 102:220658k (1985). |
"Cephalosporin derivatives", Chemical Abstracts, 102:220657j (1985). |
"Antibiotic Activity of CL 118,673, a New Oral Cephalosporin", N.A. Kuck et al., Recent Advances In Chemotherapy, Proceedings of the 14th Int'l. |
Congress of Chemotherapy, Antimicrobial Section 2, pp. 1137-1138 (1985). |
Improved Synthesis of an Ester-Type Prodrug, 1-Acetoxyethyl 7-[(Z)-2-(2-Aminothiazol-4-yl)-2-Hydroxyiminoacetamido]-3-[(Z)-1-Propenyl]-3-Cephem-4-Carboxylate (BMY-28271), Hajime Kamachi et al., The Journal of Antibiotics, vol. XLIII(12:1564-1572 (1990). |
In Vivo Evaluation of Tigemonam, a Novel Oral Monobactam, Clark et al., Antimicrobial Agents and Chemotherapy, Feb. 1987, vol. 31, No. 2, p. 226-229. |
Pharmacokinetic and In Vivo Studies with Azithromycin (CP-62,993), a New Macrolike with an Extended Half-Life and Excellent Tissue Distribution, Antimicrobial Agents and Chemotherapy, Dec. 1987, vol. 31, No. 12, p. 1948-1954. |
Pharmacokinetics of FK482, A New Orally Active Cephalosporin, In Animals Sakamoto et al., The Journal of Antibiotics, vol. XLI(12):1896-1905 (1988). |
Studies on Orally Active Cephalosporin Esters, II. Chemical Stability of Pivaloyloxymethyl Esters in Phosphate Buffer Solution, Miyauchi et al. Chemical and Pharmaceutical Bulletin, 37(9) 2369-2374 (1989). |
Studies on Orally Active Cephalosporin Esters. IV. Effect of the C-3 Substituent of Cephalosporin on the Gastrointestinal Absorption in Mice, Chemical and Pharmaceutical Bulletin, 37(12) 3272-3276 (1989). |
Synthesis and Mechanisms of Decomposition of Some Cephalosporin Prodrugs, J. of Pharm. Sciences, vol. 79, No. 9, (1990), Saab et al. |
Uptake of Cephalosporin, Cephalexin, by a Dipeptide Transport carrier in the Human Intestinal Cell Line, Caco-2, Biochimica et Biophysica Acta, Dantzig et al., 1027 (1990) 211-217. |
Drug Chirality--Impact on Pharmaceutical Regulations, Conference Docementation, Oct. 24th & 25th, 1990, The London Press Centre, London EC4. |
The Relationship of Absorption Characteristics and Gastrointestinal Side Effects of Oral Antimicrobial Agents, Clinical Therapeutics, Grossman, vol. 13, No. 1, pp. 189-193 (1991). |
Absolute Bioavailability of Cefprozil after Oral Administration in Beagles Antimicrobial Agents and Chemotherapy, Barbhaiya, et al. Mar. 1992, vol. 36, No. 3, pp. 687-689. |
Comparative Pharmacokinetics of SCE-2787 and Related Antibiotics in Experimental Animals, Antimicrobial Agents and Chemotherapy, Kita et al. vol. 36, No. 11, pp. 2481-2486 (1992). |
RU 29 246, The Active Compound of the Cephalosporin Prodrug-Ester HR 916 III. Pharmacokinetic Properties and Antibacterial Activity in vivo, The Journal of Antibiotics, vol. 45, No. 6, pp. 922-931 (1992). |
Pharmacokinetics of Cefpirome Administered Intravenously or Intramuscularly to Rats and Dogs, Journal of Antimicrobial Chemotherapy, Isert, 29, Suppl. A., 31-37 (1992). |
Abstract for EP-156-771-A (Sep. 1984). |